Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1)
Clinical trial NCT03199989 · UNKNOWN
Trial details
- NCT number
- NCT03199989
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2021-07-31
- Enrollment
- 1254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.